Stocks

Timur Turlov, CEO of Freedom Holding Corp., gives investors an inside look into his personal investment portfolio. 

“The stock market correction which has come to pass in recent months is approaching its final phase. This opens up a unique opportunity for investors to buy the stocks that have lost significant value, but retained fundamental reasons for future growth and development”, said Timur Turlov, CEO of Freedom Holding Corp. 

Turlov has gathered a portfolio of 12 companies, each with a potentially interesting investment idea behind it. The expected investment period is between six months and three years with the expected return being 81%. 

 

Companies in Timur Turlov’s portfolio

Snowflake Inc. (SNOW) provides a cloud-based platform that consolidates data in a single source to be able to capture valuable business insights, create applications, and manage and share information. Snowflake remains one of the fastest-growing companies in the market. With a market cap of $45bn (£37bn) and a growth potential of 119%, the target price for one share is $310 (£253). Snowflake has steadily doubled its revenues in recent years and expects revenue growth of 94% to 96% in 2022. 

Crowdstrike Holdings Inc. (CRWD.US) develops information security software and is an industry leader in the $55bn (£45bn) market. Crowdstrike offers cloud-based endpoint security solutions on its Falcon platform. The services are provided on a subscription basis using a SaaS model. Crowdstrike is continuing to perform strongly, exceeding market expectations. In Q4, its revenues rose by 62.7% year-on-year to $431m (£351m) and the average rate of return reached a record $217m (£177m). For FY2023, the company expects revenues of $2.13 to $2.16bn (£1.7 to £1.8bn). Crowdstrike has a market cap of $35bn (£29 bn) with 57% growth potential. The target price for one share is $271 (£221). 

Datadog Inc. (DDOG.US) operates a monitoring and analytics platform for software developers and IT departments. The company had a strong performance in Q1 and is forecasting strong results for 2022. In Q4, Datadog’s revenue grew by 83% year on year to $363m (£296m), aided by the company’s expanding partnership with Amazon Web Services. As of March 31, 2022, Datadog had 2,250 customers with recurring annual revenues of $100,000 (£81,545) or more, up 60% from a year earlier. Datadog has a market cap of $32bn (£26bn) with a growth potential of 72% and a target price of $169 (£138). 

Zscaler Inc. (ZS.US) is a provider of cloud-based information security services with a growth rate above 60%. The company’s Q2 revenue grew by 62.8% year-on-year to $255.56m (£184m), beating expectations of $13.69m (£11.17m). For fiscal 2022, the company forecasts revenue in the range of $1.045 to $1.05bn (£85 to £86m) against expectations of $1.01 billion (£82m) and earnings per share (EPS) in the range of $0.54 to $0.56 (£0.44 to £0.46). Zscaler has a market cap of $21bn (£17bn) with a growth potential of 110% and a target price of $320 (£261). 

Enphase Energy Inc. (ENPH.US) is a supplier of power systems for the solar energy industry. It is a profitable company with high margins and products that outperform competitors. Enphase supplies microinverters that enhance the safety and performance of solar energy systems. The company also has digitally backed home energy storage. Enphase reported Q1 EPS of $0.79 (£0.65), beating market expectations by $0.10 (£0.08), while revenue rose by 46% to a record $441m (£360) for the quarter. The revenue forecast for the current quarter is $490m (£400m) to $520m (£424m). Enphase has a market cap of $20bn (£16bn) with a growth potential of 26% and a target price of $226 (£184). 

ZoomInfo Technologies Inc. (ZI.US) is a developer of an analytics platform for marketing companies. New product launches and geographic expansions are helping ZoomInfo maintain strong revenue growth. In Q1, the company’s revenue grew 57.7% year on year to $242m (£197bn). In February 2022, ZoomInfo launched a new marketing platform, MarketingOS for helping marketers with customer targeting. The company also completed the acquisition of Comparably and Dogpatch Advisors this year. ZoomInfo has a market cap of $17bn (£14bn) with a growth potential of 115% and a target price of $74 (£60). 

MongoDB Inc. (MDB.US) is the leading cloud platform involved in developing and delivering general-purpose databases. MongoDB is strengthening its edge over competitors by expanding its relationship with Amazon Web Services and building applications using a microservices architecture. MongoDB databases are increasingly used for complex transactions, which should increase the company’s overall addressable market.  MongoDB’s revenue grew by 55.8% in Q4, with subscription revenue up by 58%. The company has a market cap of $17m (£14m) with a growth potential of 71% and a target price of $466 (£379). 

Bill.com Holdings Inc. (BILL.US) is a provider of cloud-based software that simplifies and automates complex financial transactions for small and medium-sized businesses. The company continues to show strong growth, up by 179.4% in Q3 FY 2022. By the end of the quarter, the company had 146,600 customers and $55bn (£45bn) in payments processed. For Q4, Bill.com expects revenue in the range of $182.3m to $183.3m (£148m to £149m) versus expectations of $168.77m (£169m). Bill.com has a market cap of $11bn (£9bn) and a growth potential of 113% and a target price of $241 (£196). 

Maravai LifeSiences Inc. (MRVI.US) operates in the natural sciences. The company manufactures products that enable the development of drugs, new vaccines, and diagnostics while supporting medical research in the US and around the world. The company’s key market is expected to show continued growth. The global gene therapy market was valued at $3.8bn (£3bn) in 2019 and is forecast to reach $13bn (£11bn) by 2024. Maravai has a market cap of $8bn (£6.5bn) and a growth potential of 63% and a target price of $44 (£36).  

Avalara Inc. (AVLR.US) offers cloud-based transactional tax compliance solutions worldwide. Although Avalara has achieved annual revenues of nearly $1bn (£81m) the company still manages to grow that figure by more than 30% year on year – a testament to the large size of its market and the newness of its technology. More than 90% of Avalara’s base revenue comes from subscriptions, which provides the company with a very stable income. Avalara Inc. has a market cap of $6bn (£5bn) and a growth potential of 70% and a target price of $124 (£101).

Shockwave Medical Inc. (SWAV.US) develops and supplies technology for the treatment of cardiovascular disease. The company shows triple-digit revenue growth and revises its outlook for the year. In Q1, its revenue grew by 193.4% year-on-year. In February 2021, Shockwave launched a new coronary product, which has become a revenue growth driver. Shockwave Medical Inc. has a market cap of $5bn (£4bn) and a growth potential of 28% and a target price of $189 (£154).

Taskus Inc. (TASK.US) provides outsourced digital business services for fast-growing technology companies to represent, protect and grow their brands. Taskus continues to show rapid revenue growth, rising from 34% in Q2 2020 to 56.8% in Q1 of 2022. The retention rate in 2021 was 141%. Taskus Inc. has a market cap of $2bn (£1.6bn) and a growth potential of 130% and a target price of $39 (£32).

Posted by Akeela Zahair